UREAPLASMA INFECTION IN UTERO: PREVENTION OF NEUROLOGIC SEQUELAE

子宫内脲原体感染:预防神经系统后遗症

基本信息

  • 批准号:
    8357809
  • 负责人:
  • 金额:
    $ 3.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The objectives of this research proposal are to delineate the extent of cerebral white matter inflammation and neuronal injury caused by genital mycoplasmas (U. parvum) and to assess the efficacy of maternal antibiotic plus anti-inflammatory therapy in ameliorating fetal brain inflammation and neuronal injury. It is our hypothesis that prenatal treatment of U. parvum intra-amniotic infection (IAI) with specific antibiotics and appropriate anti-inflammatory agents will delay preterm delivery and mitigate fetal origins of neonatal cerebral white matter injury. To facilitate our studies, it is necessary to expand the scope of newborn infant care at the ONPRC by establishing a special care nursery (SCN) that will support postnatal survival of prematurely born rhesus monkeys and specific neurobehavioral assessment protocols to study postnatal neurologic sequelae. With medical direction from collaborating academic neonatologists and ONPRC veterinarians, we developed critical care management plans (i.e., respiratory support, supplemental oxygen, i.v fluids and intakes), as well as standard operating procedures to assure optimal chance of neonatal survival.
这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的, 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量, 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 这项研究的目的是描述生殖器支原体引起的大脑白色物质炎症和神经元损伤的程度(U。parvum),并评估母体抗生素加抗炎治疗在改善胎儿脑炎症和神经元损伤中的功效。我们的假设是,产前治疗U。使用特定抗生素和适当的抗炎剂治疗细小羊膜腔感染(IAI)将延迟早产并减轻新生儿脑白色物质损伤的胎儿起源。为了促进我们的研究,有必要扩大ONPRC新生儿护理的范围,建立一个特殊护理托儿所(SCN),将支持早产恒河猴的产后生存和特定的神经行为评估协议,研究产后神经后遗症。在合作学术兽医和ONPRC兽医的医学指导下,我们制定了重症监护管理计划(即,呼吸支持、补充氧气、静脉输液和摄入)以及标准操作程序,以确保新生儿存活的最佳机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peta Louise Grigsby其他文献

Peta Louise Grigsby的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peta Louise Grigsby', 18)}}的其他基金

Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
  • 批准号:
    8666013
  • 财政年份:
    2012
  • 资助金额:
    $ 3.63万
  • 项目类别:
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
  • 批准号:
    9065594
  • 财政年份:
    2012
  • 资助金额:
    $ 3.63万
  • 项目类别:
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
  • 批准号:
    8532944
  • 财政年份:
    2012
  • 资助金额:
    $ 3.63万
  • 项目类别:
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
  • 批准号:
    8372870
  • 财政年份:
    2012
  • 资助金额:
    $ 3.63万
  • 项目类别:
UREAPLASMA INVASION OF CHORION AND AMNION EPITHELIAL CELL LAYERS IN VITRO
体外解脲支原体对绒毛膜和羊膜上皮细胞层的侵袭
  • 批准号:
    8357846
  • 财政年份:
    2011
  • 资助金额:
    $ 3.63万
  • 项目类别:
COMPARTMENTAL ANALYSIS OF PROTEOMIC BIOMARKERS DURING INTRA-UTERINE INFECTIONS
子宫内感染期间蛋白质组生物标志物的区室分析
  • 批准号:
    8357791
  • 财政年份:
    2011
  • 资助金额:
    $ 3.63万
  • 项目类别:
COMPARTMENTAL ANALYSIS OF PROTEOMIC BIOMARKERS DURING INTRA-UTERINE INFECTIONS
子宫内感染期间蛋白质组生物标志物的区室分析
  • 批准号:
    8173276
  • 财政年份:
    2010
  • 资助金额:
    $ 3.63万
  • 项目类别:
UREAPLASMA INFECTION IN UTERO: PREVENTION OF NEUROLOGIC SEQUELAE
子宫内脲原体感染:预防神经系统后遗症
  • 批准号:
    8173301
  • 财政年份:
    2010
  • 资助金额:
    $ 3.63万
  • 项目类别:
COMPARTMENTAL ANALYSIS OF PROTEOMIC BIOMARKERS DURING INTRA-UTERINE INFECTIONS
子宫内感染期间蛋白质组生物标志物的区室分析
  • 批准号:
    7958555
  • 财政年份:
    2009
  • 资助金额:
    $ 3.63万
  • 项目类别:
PLACENTAL PLASTICITY, FETAL GROWTH AND DEVELOPMENTAL PROGRAMMING
胎盘可塑性、胎儿生长和发育规划
  • 批准号:
    7958484
  • 财政年份:
    2009
  • 资助金额:
    $ 3.63万
  • 项目类别:

相似海外基金

Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
  • 批准号:
    23K07659
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
  • 批准号:
    23K15705
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
  • 批准号:
    23K19490
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
  • 批准号:
    10697567
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
  • 批准号:
    10727765
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
  • 批准号:
    23K08467
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
  • 批准号:
    493138
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
  • 批准号:
    2223225
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
    Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
  • 批准号:
    10651054
  • 财政年份:
    2023
  • 资助金额:
    $ 3.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了